Conference Agenda
Day 1, Wednesday, October 28, 2020
2:00 p.m. - 2:20 p.m.
The Science of the Drug and the Injury
• Background on Elmiron
• Basic Anatomy and the Signature Injury
• Symptoms of the Injury
• Risk of Misdiagnosis
Patrick Luff, The Fears | Nachawati Law Firm, Dallas
2:20 p.m. - 2:40 p.m.
The Studies Linking Elmiron to the Signature Injury
Neil D. Overholtz, Aylstock, Witkin, Kreis & Overholtz, PLLC, Pensacola, FL
2:40 p.m. - 3:00 p.m.
Case Selection Criteria based on Science, Studies, Intake, and Case Evaluation
Hunter J. Shkolnik, Napoli Shkolnik PLLC, New York
3:00 p.m. - 3:20 p.m.
The State of the Litigation and the Pending MDL Motion
Michael A. London, Douglas & London, P.C., New York
3:20 p.m. - 3:30 p.m.
Roundtable Discussion of Any Issues that Are Unique to the Elmiron Litigation
Michael A. London, Douglas & London, P.C., New York
Neil D. Overholtz, Aylstock, Witkin, Kreis & Overholtz, PLLC, Pensacola, FL
Hunter J. Shkolnik, Napoli Shkolnik PLLC, New York
Patrick Luff, The Fears | Nachawati Law Firm, Dallas